The Chimeric (ASX:CHM) share price jumps 6% on patent success

Chimeric's shares are on the move this afternoon. Here's the details.

| More on:
Happy child jumping for joy.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

The Chimeric Therapeutics Ltd (ASX: CHM) share price has jumped 6% into the green during afternoon trade, and currently trades at 33.5 cents.

Chimeric shares are rallying after the company announced a key update regarding its CAR Technology.

Read on for more details.

What did Chimeric Therapeutics announce?

Chimeric advised that the European Patent Office has granted the company a patent covering its chimeric antigen receptor (CAR) technology.

CAR Therapy is being developed for patients with Glioblastoma, where it is currently being studied in a phase 1 trial at City of Hope Medical Centre in the US.

The patent covers "certain applications" of the CAR technology using cholorotoxin (CLTX), and also the company's clinical-stage label CHM 1101.

It was published in the "European Patent Bulletin dated September 22, 2021", according to Chimeric, under patent number EP 3,362,470 B1.

Effectively the patent grants protection for CAR over these "applications" that will use CLTX and CHM 1011 until 2036.

In addition, Chimeric also "holds the exclusive worldwide license" to commercialise the patent, and "related patent applications filed in other global territories" for the compound.

This is an important milestone for clinical-stage biotechnology companies, as they need to secure the rights to sell their compounds if they can successfully develop them.

Investors appear to love the news and are pushing the Chimeric Therapeutics share price towards its previous high of 35 cents on 7 September.

What did management say?

Speaking on the patent milestone, Chimeric's CEO and managing director, Jennifer Chow said:

We are pleased to see the continued advancement of the strong intellectual property portfolio underpinning Chimeric's CLTX CAR T program, on this occasion in a geography that holds significant market potential.

Chimeric share price snapshot

The Chimeric Therapeutics share price has had a very difficult year to date and has posted a return of 14% since listing in January.

However, over the last month, it has stepped a further 1.5% into the green and is also up another 3% this past week.

It is still early days for Chimeric, but it is still trading ahead of the S&P/ASX 200 index (ASX: XJO)'s year to date gain of 12%.

At the time of writing, Chimeric Therapeutics has a market capitalisation of $105 million.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Unsure man analysing data on laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing end to a disappointing week for investors this Friday.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Betr, Centuria Capital, GR Engineering, and Mach7 shares are pushing higher

These shares are having a good finish to the week. But why?

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX gave up an afternoon lead to close lower today.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Clarity Pharmaceuticals, Kelsian, Life360, and Syrah shares are rising today

These shares are pushing higher on Thursday. But why?

Read more »

Man smiling on top of rocks with mountains in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors were in a nervous mood today.

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Share Gainers

Why Beach Energy, Boss Energy, Cochlear, and Light & Wonder shares are pushing higher

These shares are having a good time on hump day. But why?

Read more »

A man looking at his laptop and thinking.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing Tuesday session for ASX investors today.

Read more »

A man looking at his laptop and thinking.
Share Gainers

Thinking of selling your CBA shares? This expert says you should hold on

CBA shares are up by about 80% since November 2023.

Read more »